Intrabacterial macromolecules

Intrabacterial macromolecules refer to the broad set of large biological molecules found within the bacterial cytoplasm, including DNA, RNA, ribosomes, and various enzymes (Walsh, C., 2003, Antibiotics: Actions, Origins, Resistance). These molecules are the functional targets for numerous classes of antibiotics; for example, fluoroquinolones inhibit DNA gyrase and topoisomerase IV to prevent DNA replication, while aminoglycosides and macrolides target the 30S and 50S ribosomal subunits, respectively, to inhibit protein synthesis (Wilson, D. N., 2014, Nature Reviews Microbiology). Because these macromolecules are essential for bacterial viability and proliferation, they are central to the treatment of bacterial infections (Bush, K., 2010, Nature Reviews Microbiology). However, the term is a collective descriptor rather than a specific molecular target, encompassing hundreds of distinct potential therapeutic sites. A major challenge in targeting these molecules is the necessity for drugs to penetrate the bacterial cell envelope, often overcoming efflux pumps and low-permeability barriers (Silver, L. L., 2011, Clinical Microbiology Reviews). Furthermore, mutations in these macromolecules frequently lead to the development of antimicrobial resistance, a significant global health concern (Blair, J. M., et al., 2015, Nature Reviews Microbiology). Targeting these components also requires high specificity to avoid cross-reactivity with human homologs, such as mitochondrial ribosomes, which can lead to host toxicity.

Other names

Bacterial intracellular targetsBacterial cytoplasmic macromoleculesEndocellular bacterial components

Inhibition of essential intracellular processes including nucleic acid synthesis (DNA replication and RNA transcription), protein translation at the ribosome, and key enzymatic metabolic pathways.